SCHEMBL7782691

SCHEMBL7782691

CCC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)OC(C(=O)O)c1ccccc1.CCC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)Oc1ccc(C(=O)O)c(CI)c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
LMNA P02545 2/20 0.45
CTSL P07711 4/20 0.44
CTSS P25774 4/20 0.44
CTSB P07858 2/20 0.44
CYP3A4 P08684 3/20 0.44
CYP2C9 P11712 3/20 0.44
CYP2C19 P33261 2/20 0.44
CYP2D6 P10635 1/20 0.44
RAB9A P51151 1/20 0.44
CTSK P43235 1/20 0.42
CASP3 P42574 2/20 0.41
ATM Q13315 2/20 0.39
MME P08473 1/20 0.39
ECE1 P42892 1/20 0.39
TSHR P16473 2/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7782692 1.00 MEN1 (0.45) MEN1KMT2ALMNACTSLCTSS
SCHEMBL3733758 0.83 MEN1 (0.61) MEN1KMT2ALMNACTSLCTSS
SCHEMBL3733757 0.83 MEN1 (0.61) MEN1KMT2ALMNACTSLCTSS
SCHEMBL3729617 0.81 CYP3A4 (0.50) MEN1KMT2ALMNACTSLCTSS
SCHEMBL3737297 0.76 MEN1 (0.55) MEN1KMT2ALMNACTSLCTSS
SCHEMBL3735332 0.75 CTSL (0.59) MEN1KMT2ALMNACTSLCTSS
SCHEMBL3735328 0.75 CTSL (0.59) MEN1KMT2ALMNACTSLCTSS
SCHEMBL3727263 0.74 CTSL (0.54) MEN1KMT2ALMNACTSLCTSS
SCHEMBL7669423 0.73 RAB9A (0.42) MEN1KMT2ALMNACTSLCTSS
SCHEMBL3738178 0.73 MEN1 (0.48) MEN1KMT2ACTSLCTSSCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1150956-A1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MEDIVIR AB (SE) 2001-11-07 EP disclosed
WO-2000047561-A1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MEDIVIR AB (SE) 2000-08-17 WO disclosed